Groups | Peripheral blood | Bone marrow | ||||||
---|---|---|---|---|---|---|---|---|
MWBCs (×109/L) | MERw (%) | MMCs (×109/L) | MERm (%) | BMHD | MIQAS | MMCs (×109/L) | MERm (%) | |
The first control | 5.7 ± 1.3 | 1.1 ± 0.4 | 2.7 ± 1.5 | 1.4 ± 0.5 | Activity | 21.4 ± 4.5 | 12.8 ± 2.5 | 48 ± 4.3 |
The second control | 2.1 ± 0.7 | 6 ± 1.2 | 1.7 ± 0.6 | 10.3 ± 1.7 | Low or extremely low | 3.2 ± 1.4a | 5.3 ± 1.4a | 16.7 ± 1.6a |
30 days after HSCT | 2.5 ± 1.0a | 13.6 ± 1.6a | 1.5 ± 0.4 | 17.8 ± 1.9a | Activity | 43.3 ± 4.1a,b | 6.6 ± 1.7a | 23.5 ± 1.2a |
90 days after HSCT | 3.2 ± 1.2a | 15.4 ± 1.8a | 2.2 ± 0.7 | 19.7 ± 1.4a | More activity | 46.2 ± 3.6a,b | 10.4 ± 1.5a | 31.2 ± 1.8a |
180 days after HSCT | 3.0 ± 1.1a | 14.2 ± 1.5a | 2.1 ± 0.8 | 18.5 ± 1.6a | Activity | 44.7 ± 4.2a,b | 8.8 ± 1.2a | 33.4 ± 1.1a |